NMRA: Neumora Therapeutics Inc. Stock

by  •  • Comments Off on NMRA: Neumora Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,844.66
Enterprise Value ($M) 2,276.06
Book Value ($M) 512.69
Book Value / Share 3.36
Price / Book 3.60
NCAV ($M) 493.68
NCAV / Share 3.23
Price / NCAV 3.74

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 18.05
Current Ratio 18.05

Balance Sheet (mrq) ($M)
Current Assets 525.74
Assets 544.75
Liabilities 32.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-02 13D ARCH Venture Fund XII, L.P. 19.60
09-27 13D Amgen Inc 23.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-11-29 55,434 202,060 27.43
2023-11-28 36,292 120,440 30.13
2023-11-27 30,539 127,310 23.99
2023-11-24 11,632 97,356 11.95

(click for more detail)

Similar Companies
NKTX – Nkarta Inc NLSP – NLS Pharmaceutics Ltd
NLTX – Neoleukin Therapeutics Inc NMTR – 9 Meters Biopharma Inc
NOVN – Novan Inc


Financial data and stock pages provided by
Fintel.io